QTUM vs. QNTM
QTUM (Defiance Quantum ETF) is Technology Equities fund tracking the BlueStar Machine Learning and Quantum Computing Index, while QNTM (Quantum BioPharma Ltd) is a stock. Over the past 5 years, QTUM returned 24.56%/yr vs -52.03%/yr for QNTM. Their 0.20 correlation means their historical movements had little consistent relationship.
Performance
QTUM vs. QNTM - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, QTUM achieves a 29.28% return, which is significantly higher than QNTM's -60.41% return.
QTUM
- 1D
- 0.67%
- 1M
- -8.88%
- 6M
- 22.33%
- YTD
- 29.28%
- 1Y
- 57.72%
- 3Y*
- 39.51%
- 5Y*
- 24.56%
- 10Y*
- —
- ALL TIME*
- 25.62%
QNTM
- 1D
- 1.76%
- 1M
- -17.66%
- 6M
- -36.90%
- YTD
- -60.41%
- 1Y
- -87.81%
- 3Y*
- -67.70%
- 5Y*
- -52.03%
- 10Y*
- —
- ALL TIME*
- -51.98%
Liquidity Comparison
| Position | Avg. Volume Value (2W) | Avg. Volume Value (1M) | Avg. Volume Value (3M) |
|---|---|---|---|
| $262.51K | $263.06K | $1.42M | |
| $54.21M | $61.13M | $111.15M |
QTUM vs. QNTM - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|---|---|---|
QTUM Defiance Quantum ETF | 29.28% | 36.65% | 50.54% | 39.86% | -28.80% | 35.18% | 42.05% | 47.99% | -19.44% |
QNTM Quantum BioPharma Ltd | -60.41% | 98.37% | -93.84% | 16.67% | -22.71% | -34.62% | -71.27% | -87.38% | -17.05% |
Correlation
The correlation between QTUM and QNTM is 0.12, which is low. Their historical price movements had little consistent relationship.
| Correlation | |
|---|---|
Correlation (1Y) Focuses on recent behavior, but can change the most. | 0.12 |
Correlation (3Y) Balances recent behavior with more history. | 0.17 |
Correlation (5Y) Shows whether the relationship held over a longer period. | 0.18 |
Correlation (All Time) Calculated using the full available price history since Sep 5, 2018 | 0.20 |
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
QTUM vs. QNTM — Risk / Return Rank
QTUM
QNTM
QTUM vs. QNTM - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Defiance Quantum ETF (QTUM) and Quantum BioPharma Ltd (QNTM). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| QTUM | QNTM | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +2.35 | ||
| Sortino ratioReturn per unit of downside risk | +3.59 | ||
| Omega ratioGain probability vs. loss probability | 1.29 | 0.87 | +0.42 |
| Calmar ratioReturn relative to maximum drawdown | 2.57 | -0.95 | +3.52 |
| Martin ratioReturn relative to average drawdown | 9.41 | -1.19 | +10.60 |
Loading charts...
Drawdowns
QTUM vs. QNTM - Drawdown Comparison
The maximum QTUM drawdown since its inception was -38.45%, smaller than the maximum QNTM drawdown of -99.98%. Use the drawdown chart below to compare losses from any high point for QTUM and QNTM.
Loading charts...
Drawdown Indicators
| QTUM | QNTM | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -38.45% | -99.98% | +61.53% |
Max Drawdown (1Y)Largest decline over 1 year | -21.51% | -92.81% | +71.30% |
Max Drawdown (3Y)Largest decline over 3 years | -25.39% | -97.98% | +72.59% |
Max Drawdown (5Y)Largest decline over 5 years | -38.45% | -98.42% | +59.97% |
Current DrawdownCurrent decline from peak | -16.16% | -99.97% | +83.81% |
Average DrawdownAverage peak-to-trough decline | -8.27% | -92.34% | +84.07% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 5.87% | 73.68% | -67.81% |
Volatility
QTUM vs. QNTM - Volatility Comparison
The current volatility for Defiance Quantum ETF (QTUM) is 11.38%, while Quantum BioPharma Ltd (QNTM) has a volatility of 16.50%. This indicates that QTUM experiences smaller price fluctuations and is considered to be less risky than QNTM based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| QTUM | QNTM | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 11.38% | 16.50% | -5.12% |
Volatility (6M)Calculated over the trailing 6-month period | 26.47% | 106.32% | -79.85% |
Volatility (1Y)Calculated over the trailing 1-year period | 31.67% | 146.13% | -114.46% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 27.69% | 134.30% | -106.61% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 27.69% | 139.57% | -111.88% |
Dividends
QTUM vs. QNTM - Dividend Comparison
QTUM's dividend yield for the trailing twelve months is around 0.83%, while QNTM has not paid dividends to shareholders.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
QNTM Quantum BioPharma Ltd | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
QTUM Defiance Quantum ETF | 0.83% | 1.01% | 0.61% | 0.81% | 1.46% | 0.48% | 0.42% | 0.61% | 0.21% |
Frequently Asked Questions
QTUM and QNTM have a correlation of 0.12, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
QNTM has higher volatility (16.50%) compared to QTUM (11.38%). In terms of maximum drawdown, QTUM dropped -38.45% vs QNTM's -99.98%.
QTUM currently has the higher Sharpe Ratio (1.75 vs -0.60), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for QTUM and QNTM
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer